Palifermin (Kepivance)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 14:33, 28 February 2024 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

From the NCI Drug Dictionary: A recombinant form of the endogenous human keratinocyte growth factor. Palifermin binds to epithelial cell surface receptors in the lining of the mouth and gastrointestinal tract, resulting in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms.

Also known as

  • Generic name: rhKGF
  • Brand name: Kepivance